Scarica l'app Stockscreener
46.41
1.20%
1.11
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRNA Giù?
Forum
Previsione
Moderna Inc Borsa (MRNA) Ultime notizie
Jim Cramer on Moderna: “We Have to Wait and See” - Insider Monkey
U.S. vaccine hesitancy could impact investment - Axios
Moderna, Inc. $MRNA Shares Sold by Federated Hermes Inc. - MarketBeat
This Stock Is Already Up 58% This Year. Is It a Buy? - Finviz
Promising Biotech Stocks To ResearchJanuary 28th - MarketBeat
Wolfe Adjusts Price Target on Moderna to $25 From $17, Maintains Underperform Rating - marketscreener.com
Moderna (MRNA) Leads Healthcare Stocks with Impressive Gains - GuruFocus
Top performing healthcare stocks in the past month (MRNA:NASDAQ) - Seeking Alpha
Moderna (NASDAQ:MRNA) Coverage Initiated at Barclays - MarketBeat
Roche Makes Obesity Splash, Moderna Cans Vaccine Trials, Sarepta’s New Data, More - BioSpace
Analyst Calls: Can Moderna Inc continue delivering strong returns2025 Year in Review & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Oncolytics Biotech Strengthens Leadership for Oncology Trials - Intellectia AI
US Stocks Recap: What are the future prospects of Moderna IncBuy Signal & Weekly High Conviction Ideas - baoquankhu1.vn
Moderna (MRNA) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Stock Market Today, Jan. 20: ImmunityBio Soars Again After FDA Outlines Resubmission Path for ANKTIVA in Bladder Cancer - The Motley Fool
Moderna (MRNA) stock slips; Feb. 13 earnings call is the next catalyst for the share price - TechStock²
Behind the Scenes of Moderna's Latest Options Trends - Benzinga
Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026 - ACCESS Newswire
Aug Momentum: Is Moderna Inc a momentum stockJuly 2025 Levels & Capital Protection Trading Alerts - baoquankhu1.vn
Moderna shifts focus in response to US vaccine skepticism - medwatch.com
CEPI to Fund Pivotal Phase 3 Trial for Moderna's mRNA Pandemic Influenza Vaccine Candidate - lansingstatejournal.com
Promising Biotech Stocks To Follow TodayJanuary 25th - MarketBeat
Moderna Expands U.S. Manufacturing with Onshoring of Drug Product Capabilities - hattiesburgamerican.com
Hecla Mining, Moderna, And Micron Are Among the Top 10 Large-Cap Gainers Last Week (Jan. 19-Jan. 23): Are the Others in Your Portfolio?First Majestic Silver (NYSE:AG), Coeur Mining (NYSE:CDE), Hecla Mining (NYSE:HL), Iamgold (NYSE:IAG) - Benzinga
Aug PostEarnings: Is Moderna Inc a turnaround storyMarket Trend Summary & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Aug PreEarnings: Will TriSalus Life Sciences Inc benefit from rate cutsJuly 2025 Movers & Reliable Intraday Trade Alerts - baoquankhu1.vn
Moderna downsizing investments in late-stage vaccine trials amid U.S. skepticism (Video) - Social News XYZ
Moderna stock pulls back after a sharp rally as investors weigh U.S. vaccine backlash risk - TechStock²
Why Moderna (MRNA) Is Up 16.4% After Five-Year Data On Personalized Melanoma mRNA Therapy - Yahoo Finance
Moderna, Inc. $MRNA Shares Sold by Baillie Gifford & Co. - MarketBeat
Moderna downsizing investments in late-stage vaccine trials amid U.S. skepticism - Yahoo
Moderna Options Spot-On: On January 23rd, 191.29K Contracts Were Traded, With 974.59K Open Interest - 富途资讯
The Globe’s stars and dogs for the week - The Globe and Mail
Moderna's Growth Strategy Seen as Reassuring Investors -- Market Talk - 富途资讯
Healthcare Sector Declines 1.2%, Moderna Falls 7.2% Amidst Market Weakness - Intellectia AI
Promising Biotech Stocks Worth WatchingJanuary 23rd - MarketBeat
Moderna (NASDAQ:MRNA) Shares Gap DownHere's What Happened - MarketBeat
Moderna Won’t Run Phase III Vaccine Trials as Skepticism Grows in US: Bloomberg - BioSpace
Analyst recommendations: Amgen, P&G, Spotify, Duolingo, Moderna… - marketscreener.com
Moderna Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference - sj-r.com
Moderna (MRNA) stock jumps after-hours as CEO signals pullback in new vaccine trials - TechStock²
Intel, GE Aerospace, Moderna, Abbott, Mobileye, McCormick, and More Stock Movers - Barron's
Moderna (NASDAQ:MRNA) Trading Up 10.2%Time to Buy? - MarketBeat
Moderna Stock Soars. Why a Cancer Vaccine Study Has Sparked a Rally. - Barron's
Moderna and Merck Solidify Oncology Leadership as Five-Year Melanoma Data Fuels Market Rally - FinancialContent
Moderna (MRNA) Halts Phase 3 Vaccine Development Amid U.S. Regulatory Challenges - GuruFocus
Moderna (MRNA) Sees Bullish Activity with Increased Options Trading - GuruFocus
Moderna is curbing investment in vaccine trials due to US backlash - MSN
Moderna cutting R&D on vaccines amid U.S. pushback: CEO (MRNA) - Seeking Alpha
Moderna curbing investments in vaccine trials due to US backlash, CEO tells Bloomberg TV - kfgo.com
Moderna-Merck mRNA Vaccine Slashes Melanoma Recurrence by 49% at 5 Years - WebProNews
Biotech Stocks To Keep An Eye OnJanuary 22nd - MarketBeat
Intel, GE Aerospace, Moderna, Abbott, Arista, Mobileye, McCormick, and More Movers - Barron's
Moderna (MRNA) Stock Surge Boosts ETFs with High Exposure - GuruFocus
Moderna (MRNA) Surges Over 20% This Week, Hits 52-Week High - GuruFocus
MRNA & MRK's Personalized Cancer Therapy Delivers Strong 5-Year Data - Yahoo Finance
Moderna (MRNA) CEO Cites U.S. Vaccine Opposition as Barrier to New Trials - GuruFocus
Moderna & Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in Patients With High-Risk Stage III/IV Melano - dispatch.com
Moderna’s rally ripples through biotech and health care ETFs - Seeking Alpha
Moderna (MRNA) Shares Surge to New 52-Week High - GuruFocus
Moderna shares soar through the week, momentum data points toward caution - MSN
1.76%
0.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):